144
Participants
Start Date
April 1, 2025
Primary Completion Date
November 1, 2025
Study Completion Date
December 1, 2025
Saline
Group I (Group C): (control group) Patients in this group will receive only 5 ml of intranasal saline.
Dexmedetomidine
Group II (Group D): Patients in this group will receive only intranasal Dexmedetomidine (1 mcg/kg) made up to 5 ml in normal saline.
Midazolam
Group III (Group M): Patients in this group will receive only intranasal midazolam (0.2 mg/kg) made up to 5 ml in normal saline.
Bupivacaine
Group IV (Group B): Patients in this group will receive only intranasal bupivacaine (0.5% solution) 5 ml.
Faculty of Medicine, Minya
Minia University
OTHER